Current therapeutic approaches for HBV infected patients

Affiliations

¹ Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine & Dentistry, QMUL, London, UK.
² Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine & Dentistry, QMUL, London, UK. Electronic address: p.kennedy@qmul.ac.uk.

Upkar S Gill et al. J Hepatol. 2017 Aug.

. 2017 Aug;67(2):412-414.

doi: 10.1016/j.jhep.2017.04.015. Epub 2017 Jun 17.

¹ Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine & Dentistry, QMUL, London, UK.
² Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine & Dentistry, QMUL, London, UK. Electronic address: p.kennedy@qmul.ac.uk.

No abstract available

Keywords: Hepatitis B surface antigen; Novel therapeutic agents; Nucleos(t)ide analogues; Pegylated interferon; cccDNA.

Publication types